Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 19, 2010Blood

Alternating Courses of 3x CHOP and 3x DHAP Plus Rituximab Followed by a High Dose ARA-C Containing Myeloablative Regimen and Autologous Stem Cell Transplantation (ASCT) Is Superior to 6 Courses CHOP Plus Rituximab Followed by Myeloablative Radiochemotherapy and ASCT In Mantle Cell Lymphoma: Results of the MCL Younger Trial of the European Mantle Cell Lymphoma Network (MCL net)

View Full Paper
Ask AI
Bookmark
Share

Authors

Olivier Hermine
Olivier HermineUniversité Claude Bernard Lyon 1EHEva HosterZimmer Biomet (Netherlands)JWJan WalewskiNational Institute of Oncology

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hermine et al. (2010) studied this question.

synapsesocial.com/papers/6a8e302ee7b660170a3c3bbchttps://doi.org/10.1182/blood.v116.21.110.110
View Full Paper
Ask AI
Bookmark
Share